Penetration Testing Service in
New Jersey
New Jersey hosts pharmaceutical R&D headquarters, financial services operations serving the NYC metro, and a significant chemical industry concentration. Each vertical has specific penetration testing requirements intersecting with NJ state law and NYC metro regulatory scrutiny. Digital Roxy runs manual pentests for New Jersey businesses with reports addressing NJ-specific compliance alongside federal frameworks.
Penetration Testing for New Jersey Companies
New Jersey hosts more pharmaceutical R&D than any other state. Merck, Johnson & Johnson, Bristol-Myers Squibb, Novartis, and dozens of smaller biotech companies operate major R&D and corporate functions in NJ. Penetration testing for NJ pharmaceutical requires the same industrial espionage threat modeling as PA pharma, plus NJ-specific considerations around the relationships with major academic medical centers and the federal research partnerships concentrated in the state. Digital Roxy NJ pharma engagements include threat modeling specific to pharmaceutical industrial espionage, dedicated testing phases for lab information systems (LIMS) and electronic lab notebooks, and reporting structured for SOC 2 plus the ad-hoc audit requirements of pharmaceutical development partners.
New Jersey financial services operations serve the NYC metro at lower real estate cost. Many major banks run back-office operations, data centers, and disaster recovery infrastructure in NJ. Pentest engagements for NJ financial operations need to address the specific architecture of DR/BC infrastructure: air-gapped backups, replicated environments, failover tested against production attack paths, and the unique threat of an attacker targeting DR infrastructure as a foothold.
The New Jersey chemical industry (ExxonMobil, BASF, other major chemical producers) operates critical infrastructure under CFATS (Chemical Facility Anti-Terrorism Standards) and has specific cybersecurity requirements that intersect with OT pentest methodology. Digital Roxy chemical industry engagements include explicit IT/OT separation, Purdue Model-aware testing methodology, and reports structured against CFATS cybersecurity best practices.
Medical supply and pharmaceutical distribution concentrates in NJ due to transportation infrastructure. McKesson, Cardinal Health, and other major distributors operate significant NJ infrastructure. Penetration testing for NJ pharmaceutical distribution includes DSCSA (Drug Supply Chain Security Act) compliance considerations, EDI transaction security, and the specific cyber-physical threat model of pharmaceutical logistics.
New Jersey Penetration Testing Scope & Compliance
Every Digital Roxy engagement in New Jersey is scoped against the state-specific regulatory and threat environment. Generic pentests miss what New Jersey auditors and courts actually examine.
Regulations Covered
NJ Identity Theft Prevention Act, HIPAA for NJ healthcare and pharma, CFATS (Chemical Facility Anti-Terrorism Standards), DSCSA for pharmaceutical distribution, and GLBA for NJ financial services operations.
Common Threat Patterns
Nation-state industrial espionage against pharmaceutical R&D, insider threats in pharmaceutical distribution, ransomware and extortion against financial services DR infrastructure, and supply chain attacks in pharmaceutical logistics.
Industries We Serve in New Jersey
Pharmaceutical R&D · financial services operations · chemical industry · medical supply distribution · telecommunications
Engagement Coverage
Web applications, external and internal networks, mobile applications, APIs, cloud environments (AWS, Azure, GCP), and Active Directory. Reports delivered with executive summary, technical findings, exploitation evidence, and prioritised remediation paths.
A New Jersey-Ready Pentest Partner
We do not run scanner-generated reports rebranded as penetration tests. Every New Jersey engagement is scoped, executed, and reported by a named senior engineer.
Regulation-Aware Reporting
Reports structured against the specific New Jersey regulations your business faces. Compliance mapping is built in, not bolted on.
Senior Engineers, Named Accountability
Every report is signed. Every finding is defensible under examination. No offshore labour, no junior staff, no scanner-only output.
Fast Scheduling
New Jersey engagements typically start within two weeks of signed SOW. No 90-day queues.
Fixed-Price Quotes
Every New Jersey engagement is fixed-price after a 15-minute scoping call. No scope creep, no hourly surprises.
Free Retest Included
One complimentary remediation retest within 90 days, so your New Jersey audit response is a clean-findings document.
Direct Engineer Access
Your New Jersey team talks directly with the engineer who found the vulnerability. No ticket queues, no account manager filters.
Penetration Testing in Other States
Ready for a New Jersey pentest?
Book a 15-minute scoping call. You get a fixed-price quote within one business day, with engagement scheduling typically within two weeks.